Form 4: Adaptive Biotechnologies Executive Sells Shares
Insider Transaction (Form 4)
Francis Lo, Chief People Officer of Adaptive Biotechnologies Corp, sold 105,762 shares of common stock on July 15, 2026 for $22.59 per share.
Summary
- Option exercise/conversion: acquired 59,374 Common Stock at $7.80 ($463,117) on July 15, 2026; holds 290,087 after (Direct).
- Option exercise/conversion: acquired 23,677 Common Stock at $12.14 ($287,439) on July 15, 2026; holds 313,764 after (Direct).
- Option exercise/conversion: acquired 22,711 Common Stock at $8.46 ($192,135) on July 15, 2026; holds 336,475 after (Direct).
- Open-market sale: disposed of 105,762 Common Stock at $22.59 ($2,389,164) on July 15, 2026; holds 230,713 after (Direct).
- Option exercise/conversion: disposed of 59,374 Stock Option (right to buy) on July 15, 2026 (Direct).
- Option exercise/conversion: disposed of 23,677 Stock Option (right to buy) on July 15, 2026; holds 132,246 after (Direct).
- Option exercise/conversion: disposed of 22,711 Stock Option (right to buy) on July 15, 2026; holds 37,511 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $2,389,164 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Francis Lo — Officer (Chief People Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Option exercise/conversion | Common Stock | 59,374 | $8 | $463.1K | 290,087 |
| 2026-07-15 | Option exercise/conversion | Common Stock | 23,677 | $12 | $287.4K | 313,764 |
| 2026-07-15 | Option exercise/conversion | Common Stock | 22,711 | $8 | $192.1K | 336,475 |
| 2026-07-15 | Open-market sale | Common Stock | 105,762 | $23 | $2.4M | 230,713 |
| 2026-07-15 | Option exercise/conversion | Stock Option (right to buy) | 59,374 | — | — | 0 |
| 2026-07-15 | Option exercise/conversion | Stock Option (right to buy) | 23,677 | — | — | 132,246 |
| 2026-07-15 | Option exercise/conversion | Stock Option (right to buy) | 22,711 | — | — | 37,511 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Option exercise/conversion (59,374 shares) |
| 2026-07-15 | Option exercise/conversion (23,677 shares) |
| 2026-07-15 | Option exercise/conversion (22,711 shares) |
| 2026-07-15 | Open-market sale (105,762 shares) |
| 2026-07-15 | Option exercise/conversion (59,374 shares) |
| 2026-07-15 | Option exercise/conversion (23,677 shares) |
| 2026-07-15 | Option exercise/conversion (22,711 shares) |
Keywords
insider transaction, Form 4, ADPT, Adaptive Biotechnologies Corp, bearish, Francis Lo
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.